Feasibility of Awake In‐Office Transnasal Double Balloon Dilation of the Pharyngoesophageal Segment
The Laryngoscope · 2026-05 · 136 (5) · 2107-2112
DOI: 10.1002/lary.70362 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 10.01.2026. Verfasst von Christine M Clark und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head & Neck Surgery, Sean Parker Institute for the Voice, Weill Cornell Medical College, New York, New York, USA. Hauptthemen laut MEDLINE: Catheterization, Ambulatory Surgical Procedures, Dilatation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Objectives
To review experience with and describe the feasibility of unsedated in‐office transnasal double balloon dilations of the pharyngoesophageal segment (PES).
Methods
Adults who underwent office‐based transnasal double balloon dilations of the PES at a single academic institution over a 3‐year period were retrospectively studied. Clinicodemographic data, prior PES dilation history, procedural indications, pre‐procedure anxiolytic usage, procedural data including the number of office‐based double balloon dilation procedures performed and dilation diameter, complications, and subjective outcomes at 2 weeks post‐dilation were recorded.
Results
Nineteen office‐based double balloon dilations to 24 mm (12 + 12‐mm balloons) were performed in seven patients (mean age: 65.3 years, 57.1% female). Indications for dilation were varied. Two (28.6%) patients had a history of oropharyngeal cancer treated with radiation therapy. No patients were post‐laryngectomy. The majority (85.7%) of patients underwent at least one prior in‐office transnasal single balloon dilation. Two (28.6%) patients required a pre‐procedure anxiolytic. One complication occurred involving post‐procedure epistaxis that resolved with topical oxymetazoline application. No esophageal lacerations or perforations were encountered. No procedures required early termination due to poor patient tolerance. The majority (71.4%) of patients reported subjective improvement in dysphagia symptoms at 2‐week follow‐up.
Conclusion
Double balloon dilation of the PES is feasible in unsedated patients in the office setting. Level of Evidence 4
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology - Head & Neck Surgery, Sean Parker Institute for the Voice, Weill Cornell Medical College, New York, New York, USA.
ORCID-Profile: Can Doruk, Valentina Mocchetti, Anaïs Rameau
Förderung
- NIA NIH HHS
- NIH HHS
- National Institute on Aging
- Common Fund
Zitieren
APA
Clark, C. M., Doruk, C., Mocchetti, V., & Rameau, A. (2026). Feasibility of Awake In‐Office Transnasal Double Balloon Dilation of the Pharyngoesophageal Segment. The Laryngoscope, 136(5), 2107-2112. https://doi.org/10.1002/lary.70362
Vancouver
Clark CM, Doruk C, Mocchetti V, Rameau A. Feasibility of Awake In‐Office Transnasal Double Balloon Dilation of the Pharyngoesophageal Segment. The Laryngoscope. 2026;136(5):2107-2112. doi:10.1002/lary.70362
BibTeX
@article{Clark2026,
author = {Clark, Christine M and Doruk, Can and Mocchetti, Valentina and Rameau, Anaïs},
title = {Feasibility of Awake In‐Office Transnasal Double Balloon Dilation of the Pharyngoesophageal Segment},
journal = {The Laryngoscope},
year = {2026},
volume = {136},
number = {5},
pages = {2107--2112},
doi = {10.1002/lary.70362}
}
EUVIMED